Stockreport

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

BiomX Inc. COmmon Stock  (PHGE) 
PDF Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on Company’s prior Phase 2 success  BiomX expe [Read more]